Fate Therapeutics, Inc. (FATE)
1.22
-0.12
(-8.96%)
USD |
NASDAQ |
Nov 13, 10:51
Fate Therapeutics Net Income (Annual) : -136.32M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -136.32M |
| December 31, 2024 | -186.26M |
| December 31, 2023 | -160.93M |
| December 31, 2022 | -281.72M |
| December 31, 2021 | -212.15M |
| December 31, 2020 | -173.39M |
| December 31, 2019 | -98.15M |
| December 31, 2018 | -66.60M |
| Date | Value |
|---|---|
| December 31, 2017 | -42.95M |
| December 31, 2016 | -33.46M |
| December 31, 2015 | -29.99M |
| December 31, 2014 | -25.88M |
| December 31, 2013 | -20.89M |
| December 31, 2012 | -14.24M |
| December 31, 2011 | -13.43M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| AVITA Medical, Inc. | -48.59M |
| Agenus, Inc. | -3.083M |
| Amgen, Inc. | 7.711B |
| Anika Therapeutics, Inc. | -9.979M |
| BioCryst Pharmaceuticals, Inc. | 263.86M |